New frontiers in nanomedicine at Rome, Italy
Pulsus group plans the International Conference on Nanomedicine and Nanotechnology (Nanomedicine 2018) scheduled during August 20-21, 2018 at Rome, Italy for the leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Nanomedicine. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Nanomedicine.
During the conference, meet the global experts from Nanomedicine Community Ching-An peng, University of Idaho, USA; Alexander Seifalian, The London BioScience Innovation Centre, London; Tomasz Puzyn, University of Gdansk, Poland; Farid Meena, Fluorotronics Inc., USA; Samaa El-Dek, Beni-suef University, Egypt; Henrique Faneca, University of Coimbra, Portugal; Abbas Amini, Western Sydney University, Australia; Khaled Abbas Helmy Abdou, Beni Suef University, Egypt; Paolo Ferruti, University of Naples, Italy; Elsayed Mohamed Abdel wahed, Petrochemical Company, Egypt; Ziyad S. Haidar, Center for Research in Biology and Oral Regeneration (CIBRO), Chile.
Nanomedicine 2018 will have a discussion on Novel Nanoparticulate Protein Therapy for Salivary Gland Radio-Protection to Improve the Quality of Life of Head & Neck Cancer Patients: A BioMAT\-\-X Approach / Core-Shell Solid Lipid Nanoparticles for the Targeted Delivery of Paclitaxel: a proof-of-concept study in breast cancer cells / Leukocyte and Platelet-rich Fibrin bioScaffolds incorporating Human Gingival Mesenchymal Stem Cells for Oro-Dental and Maxillo-Facial Surgery: Nanoparticle-Assisted Stem Cell Regenerative Therapy; Development of novel nanosystems to mediate combined and multi-target antitumor therapeutic strategies; A new hypolipidemic drug from the traditional medicine of China; Nanoparticles as new tools for inhibition of cancer angiogenesis;Determination of Infrared, Raman, (1H and 13C)-NMR and Density of State of Nateglinide Oral Antidiabetic Drug and many more.
300+ Participation (70 Industry: 30 Academia)
5+ Keynote Speakers
50+ Plenary Speakers
14 Innovative Educational Sessions
If you would like to know more information about this conference, To book a slot, Sponsorship and Exhibit sales information, please Contact: Yuva Danniel
Email: email@example.com or visit: